John Paulson suffers tall poppy syndrome
Can't get no satisfaction
Any hint of negative numbers, and hedge fund watchers wonder if he has lost his touch. He deserves the benefit of the doubt. But it's almost unavoidable that his stellar record will be cut down to size. His firm's $30 bln scale and directionless markets make it hard to shine.
This content is for Subscribers only
To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.